Newbury Pharmaceuticals Financials
| NEWBRY Stock | 3.40 0.08 2.30% |
Newbury |
Please note, the presentation of Newbury Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Newbury Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Newbury Pharmaceuticals' management manipulating its earnings.
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0015244884 |
| Business Address | Scheeletorget 1, Lund, |
| Sector | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.newburypharma.com |
| Phone | 46 46 12 11 20 |
You should never invest in Newbury Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Newbury Stock, because this is throwing your money away. Analyzing the key information contained in Newbury Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Newbury Pharmaceuticals Key Financial Ratios
Newbury Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Newbury Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Newbury Pharmaceuticals over time and compare it to other companies across industries.Newbury Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Newbury Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Newbury Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Newbury Pharmaceuticals competition to find correlations between indicators driving Newbury Pharmaceuticals's intrinsic value. More Info.Newbury Pharmaceuticals AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Newbury Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Newbury Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Newbury Pharmaceuticals Systematic Risk
Newbury Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Newbury Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Newbury Pharmaceuticals correlated with the market. If Beta is less than 0 Newbury Pharmaceuticals generally moves in the opposite direction as compared to the market. If Newbury Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Newbury Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Newbury Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Newbury Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Newbury Pharmaceuticals February 7, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Newbury Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Newbury Pharmaceuticals AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Newbury Pharmaceuticals AB based on widely used predictive technical indicators. In general, we focus on analyzing Newbury Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Newbury Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 10.95 | |||
| Value At Risk | (3.80) | |||
| Potential Upside | 4.22 |
Complementary Tools for Newbury Stock analysis
When running Newbury Pharmaceuticals' price analysis, check to measure Newbury Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Newbury Pharmaceuticals is operating at the current time. Most of Newbury Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Newbury Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Newbury Pharmaceuticals' price. Additionally, you may evaluate how the addition of Newbury Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |